Jeevan Scientific Technology Shows Improved Financial Stability Amid Operational Challenges

Jeevan Scientific Technology, a microcap player in the healthcare services sector, has recently undergone a financial trend adjustment, reflecting a more stable performance in its latest quarter ending September 2025. The company's financial score has shown notable improvement, indicating a shift towards a more balanced financial standing.
Key metrics reveal that operating cash flow has reached a peak of Rs 10.07 crore, showcasing a strong operational capability. However, challenges remain evident, particularly with the profit after tax for the quarter, which has reported a significant decline. Additionally, the inventory turnover ratio and debtors turnover ratio are at their lowest levels, suggesting inefficiencies in inventory management and receivables collection.

In terms of market performance, Jeevan Scientific Technology has demonstrated resilience compared to the Sensex. Over the past month, the stock has returned 20.37%, significantly outpacing the Sensex's 2.87% return. Year-to-date, the company has achieved a return of 27.95%, while the Sensex has recorded 8.38%. Despite some hurdles, the company's recent financial adjustments and market performance indicate a complex but evolving landscape in the healthcare services industry.